​

Funding Round

Series A - Cerebral Therapeutics

Series A - Cerebral Therapeutics

Investment Firm

Overview

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

Announced Date

Jun 20, 2018

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Vivo Capital

Vivo Capital

Vivo Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Granite Point Capital

Granite Point Capital

Granite Point Capital is a early_stage_venture and late_stage_venture and venture firm.

Participant Investors

2

Investor Name
Participant InvestorGranite Point Capital
Participant InvestorVivo Capital

Round Details and Background

Cerebral Therapeutics raised $3000000 on 2018-06-20 in Series A

Cerebral Therapeutics is a clinical-stage pharmaceutical company.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jun 20, 2018
Series A - Cerebral Therapeutics
2-3.0M
Mar 08, 2019
Series A - Cerebral Therapeutics
2-7.8M
Jan 06, 2020
Series B - Cerebral Therapeutics
4-35.0M
Jun 28, 2022
Series C - Cerebral Therapeutics
5-40.0M

Recent Activity

There is no recent news or activity for this profile.